$200,000 of CENOVUS US CORPORATION (FKA CENOVUS ENERGY) lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Renewable Fuel Standard (RFS) issues relating to the Small Refinery Exemption program, RIN obligations, and Reid Vapor Pressure requirements, including H.R. 1346 and S. 593 Issues relating to EPA Refinery Risk Management Plan
Potential impacts of tariffs on energy imports; issues relating to trade"
You can find more data on corporate lobbying on Quiver Quantitative.
CVE Hedge Fund Activity
We have seen 238 institutional investors add shares of CVE stock to their portfolio, and 181 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL WORLD INVESTORS removed 36,579,989 shares (-32.5%) from their portfolio in Q1 2026, for an estimated $970,467,108
- PRICE T ROWE ASSOCIATES INC /MD/ added 23,907,299 shares (+inf%) to their portfolio in Q1 2026, for an estimated $634,260,642
- CAPITAL RESEARCH GLOBAL INVESTORS removed 19,067,968 shares (-15.3%) from their portfolio in Q1 2026, for an estimated $505,873,191
- HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND removed 14,895,479 shares (-96.6%) from their portfolio in Q1 2026, for an estimated $395,177,057
- BANK OF AMERICA CORP /DE/ added 11,992,596 shares (+111.3%) to their portfolio in Q1 2026, for an estimated $318,163,571
- GOLDMAN SACHS GROUP INC added 8,889,079 shares (+115.5%) to their portfolio in Q1 2026, for an estimated $235,827,265
- TORONTO DOMINION BANK removed 6,034,888 shares (-56.3%) from their portfolio in Q1 2026, for an estimated $160,105,578
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
CVE Analyst Ratings
Wall Street analysts have issued reports on $CVE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Scotiabank issued a "Sector Outperform" rating on 05/07/2026
To track analyst ratings and price targets for CVE, check out Quiver Quantitative's $CVE forecast page.
CVE Price Targets
Multiple analysts have issued price targets for $CVE recently. We have seen 4 analysts offer price targets for $CVE in the last 6 months, with a median target of $44.0.
Here are some recent targets:
- Kevin Fisk from Scotiabank set a target price of $47.0 on 06/26/2026
- Greg Pardy from RBC Capital set a target price of $47.0 on 05/19/2026
- Manav Gupta from UBS set a target price of $41.0 on 04/09/2026
- Neil Mehta from Goldman Sachs set a target price of $29.0 on 03/12/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
Read full article here »
View the Zacks #1 Rank List
Lobbying Update: $200,000 of CENOVUS US CORPORATION (FKA CENOVUS ENERGY) lobbying was just disclosed
$200,000 of CENOVUS US CORPORATION (FKA CENOVUS ENERGY) lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Renewable Fuel Standard (RFS) issues relating to the Small Refinery Exemption program, RIN obligations, and Reid Vapor Pressure requirements, including H.R. 1346 and S. 593 Issues relating to EPA Refinery Risk Management Plan Potential impacts of tariffs on energy imports; issues relating to trade"
You can find more data on corporate lobbying on Quiver Quantitative.
CVE Hedge Fund Activity
We have seen 238 institutional investors add shares of CVE stock to their portfolio, and 181 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
CVE Analyst Ratings
Wall Street analysts have issued reports on $CVE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
To track analyst ratings and price targets for CVE, check out Quiver Quantitative's $CVE forecast page.
CVE Price Targets
Multiple analysts have issued price targets for $CVE recently. We have seen 4 analysts offer price targets for $CVE in the last 6 months, with a median target of $44.0.
Here are some recent targets:
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
Read full article here »